GlassScriptPhysician profile
Ali G Mansour
NPI 1346225885
$9,206.68
in general payments reported to CMS, 2019-2025
24 companies · $1,933 in 2025
The $1,933 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.76 · 2020: $654 · 2021: $1,300 · 2022: $1,055 · 2023: $2,345 · 2024: $1,834 · 2025: $1,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,088 · Education: $24.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,087.67 |
| Education | $24.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,338.52 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $1,859.39 | 2020-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $1,705.58 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,482.50 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $540.08 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $338.17 | 2023-2025 | |
| Abbott Laboratories | $135.88 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Genentech USA, INC. | $123.28 | 2019-2022 | |
| Exact Sciences Corporation | $103.58 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $103.30 | 2023-2025 | |
| Astellas Pharma US INC | $94.53 | 2024-2025 | Veozah, Cresemba |
| Merck Sharp & Dohme LLC | $87.56 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Abbvie INC. | $48.78 | 2025 | |
| Dexcom, INC. | $47.32 | 2025 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $44.87 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $36.36 | 2022 | |
| Bioventus LLC | $23.11 | 2021 | |
| Depuy Synthes Sales INC. | $17.91 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $14.16 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.55 | 2023 | Quviviq |
| Xeris Pharmaceuticals, INC. | $13.40 | 2024 | Gvoke Hypopen |
| Eisai INC. | $11.94 | 2019 | |
| Paratek Pharmaceuticals, INC. | $11.60 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.